Clinically, the nonresponder revealed significantly lower HNSCC tissue ERCC1 immunoreactivity than the responder (p = 0.0064) or control normal mucosa, which led to further mechanistic investigations. The gene discussed is ERCC1; the disease is head and neck squamous cell carcinoma.